Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen effects on physical performance
NCT00410995Phase 4Terminated
- Sponsor
- University of Oklahoma
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of naproxen in pain and inflammation, sponsored by University of Oklahoma. Primary endpoint: Maximum Oxygen Consumption. Started May 2004; status: terminated.
02
Drugs
naproxen
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT00410995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410995.